Trial Profile
The effects of neoadjuvant hormonal therapy on the course of PSA and testosterone in patients with low and intermediate-risk prostate carcinoma (NEO-ONE); A randomized controlled trial
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 07 Mar 2013
Price :
$35
*
At a glance
- Drugs Bicalutamide (Primary) ; Leuprorelin (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- Acronyms NEO-ONE
- 30 Apr 2012 New trial record